A Passion for Science and a Commitment to Dermatology

Dermavant Sciences is a biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients’ lives. The patient is at the heart of everything we do.

Learn More

Latest News

September 4, 2018

Dermavant Announces Changes to Leadership and Boar ...

Read More

August 21, 2018

Dermavant Sciences Announces Closing of Transactio ...

Read More

July 12, 2018

Roivant subsidiary Dermavant Sciences signs agreem ...

Read More